GenMark Diagnostics to Present at the 36th Annual Canaccord Genuity Growth Conference
July 27 2016 - 5:37PM
Business Wire
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems,
announced today that Hany Massarany, President and Chief Executive
Officer, will present at the 36th Annual Canaccord Genuity Growth
Conference to be held in Boston, Massachusetts at the
InterContinental Hotel on Wednesday, August 10, 2016 at 8:30 a.m.
Eastern Time. The presentation will be made available at
http://ir.genmarkdx.com.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of
automated, multiplex molecular diagnostic testing systems that
detect and measure DNA and RNA targets to diagnose disease and
optimize patient treatment. Utilizing GenMark's proprietary
eSensor® detection technology, GenMark's eSensor
XT-8® system is designed to support a broad range of molecular
diagnostic tests with a compact, easy-to-use workstation and
self-contained, disposable test cartridges. The eSensor detection
technology is also incorporated into GenMark's sample-to-answer
system, ePlex®. For more information,
visit www.genmarkdx.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160727006635/en/
GenMark Diagnostics, Inc.Hany Massarany, 760-448-4325President,
Chief Executive Officer
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2023 to Apr 2024
